Loading...
Idorsia Ltd
IDIA.SW•SIX
HealthcareBiotechnology
CHF2.02
CHF0.01(0.75%)
Idorsia Ltd (IDIA.SW) Financial Performance & Statements
Review Idorsia Ltd’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
-26.17%
↓ 26.17%
Operating Income Growth
9.07%
↑ 9.07%
Net Income Growth
11.47%
↑ 11.47%
Operating Cash Flow Growth
41.17%
↑ 41.17%
Operating Margin
-329.83%
↓ 329.83%
Gross Margin
26.61%
↑ 26.61%
Net Profit Margin
-241.92%
↓ 241.92%
ROE
24.43%
↑ 24.43%
ROIC
-573.47%
↓ 573.47%
Idorsia Ltd (IDIA.SW) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Idorsia Ltd stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $59.90M | $22.70M | $16.35M | $10.06M |
| Cost of Revenue | $52.60M | $14.97M | $5.06M | $7.37M |
| Gross Profit | $7.29M | $7.74M | $11.29M | $2.69M |
| Gross Profit Ratio | $0.12 | $0.34 | $0.69 | $0.27 |
| R&D Expenses | $32.71M | $30.91M | $34.37M | $29.50M |
| SG&A Expenses | $66.80M | $55.94M | $73.97M | $67.80M |
| Operating Expenses | $85.55M | $86.85M | $108.34M | $97.30M |
| Total Costs & Expenses | $138.16M | $101.81M | $113.40M | $104.67M |
| Interest Income | $0.00 | -$6.17M | $0.00 | $5.21M |
| Interest Expense | $0.00 | $5.07M | $4.38M | $5.21M |
| Depreciation & Amortization | $4.20M | $4.86M | $4.22M | $3.84M |
| EBITDA | -$54.85M | -$78.14M | -$99.72M | $39.06M |
| EBITDA Ratio | -$0.92 | -$3.44 | -$6.10 | $3.88 |
| Operating Income | -$78.25M | -$89.63M | -$97.05M | -$94.61M |
| Operating Income Ratio | -$1.31 | -$3.95 | -$5.94 | -$9.41 |
| Other Income/Expenses (Net) | -$5.89M | -$11.24M | -$11.27M | $124.62M |
| Income Before Tax | -$84.14M | -$100.86M | -$108.32M | $30.006M |
| Income Before Tax Ratio | -$1.40 | -$4.44 | -$6.63 | $2.98 |
| Income Tax Expense | -$136000.00 | $173000.00 | $251000.00 | $146000.00 |
| Net Income | -$84.005M | -$101.00M | -$108.57M | $29.86M |
| Net Income Ratio | -$1.40 | -$4.45 | -$6.64 | $2.97 |
| EPS | -$0.45 | -$0.56 | -$0.60 | $0.17 |
| Diluted EPS | -$0.45 | -$0.55 | -$0.60 | $0.13 |
| Weighted Avg Shares Outstanding | $188.21M | $181.58M | $179.90M | $179.12M |
| Weighted Avg Shares Outstanding (Diluted) | $188.30M | $182.38M | $179.90M | $233.27M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan